The Research Progress in Immunotherapy of Tuberculosis.

Front Cell Infect Microbiol · 2021 · PMC8634162 · PMID 34869066

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A phase III, randomized, double-blind clinical trial of the treatment of LTBI with MV carried out in 2013 showed a trend of reduced TB incidence with low adverse reactions.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.